Moderna and Immatics, a clinical-stage biopharmaceutical company based in Germany, announced a multi-platform strategic collaboration that could exceed $1.7 billion Monday morning.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,